18.97
4.86%
0.88
시장 영업 전:
18.80
-0.17
-0.90%
전일 마감가:
$18.09
열려 있는:
$18.2
하루 거래량:
486.13K
Relative Volume:
1.19
시가총액:
$834.84M
수익:
$159.01M
순이익/손실:
$-21.72M
주가수익비율:
-36.48
EPS:
-0.52
순현금흐름:
$-20.63M
1주 성능:
+4.00%
1개월 성능:
+21.29%
6개월 성능:
+108.00%
1년 성능:
+116.06%
Axogen Inc Stock (AXGN) Company Profile
명칭
Axogen Inc
전화
(386) 462-6817
주소
13631 PROGRESS BLVD., ALACHUA, FL
AXGN을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
18.97 | 834.84M | 159.01M | -21.72M | -20.63M | -0.52 |
ABT
Abbott Laboratories
|
116.79 | 201.01B | 41.22B | 5.77B | 6.49B | 3.29 |
SYK
Stryker Corp
|
395.85 | 150.90B | 21.97B | 3.59B | 3.21B | 9.33 |
BSX
Boston Scientific Corp
|
100.91 | 148.72B | 15.91B | 1.79B | 1.89B | 1.21 |
MDT
Medtronic Plc
|
88.38 | 113.33B | 33.00B | 4.29B | 5.50B | 3.27 |
EW
Edwards Lifesciences Corp
|
69.97 | 41.27B | 6.60B | 4.16B | 490.10M | 6.93 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-01 | 개시 | Raymond James | Outperform |
2022-11-11 | 재개 | Jefferies | Buy |
2022-05-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
2022-03-11 | 재개 | Cantor Fitzgerald | Overweight |
2020-10-23 | 개시 | Guggenheim | Buy |
2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
2020-05-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
2020-04-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
2019-07-12 | 개시 | Canaccord Genuity | Buy |
2018-03-02 | 재확인 | Lake Street | Buy |
2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
2017-11-30 | 개시 | Jefferies | Buy |
2017-11-21 | 재확인 | Lake Street | Buy |
2017-07-31 | 개시 | Leerink Partners | Outperform |
2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
2017-03-06 | 개시 | ROTH Capital | Buy |
2016-11-22 | 업그레이드 | Lake Street | Hold → Buy |
2016-11-07 | 재확인 | Wedbush | Outperform |
2016-11-03 | 다운그레이드 | Lake Street | Buy → Hold |
2016-08-04 | 재확인 | Wedbush | Outperform |
2014-05-14 | 개시 | Dawson James | Buy |
2013-10-31 | 재확인 | Ladenburg Thalmann | Buy |
모두보기
Axogen Inc 주식(AXGN)의 최신 뉴스
Axogen stock soars to 52-week high, touches $18.99 - Investing.com
AxoGen (NASDAQ:AXGN) Reaches New 1-Year High – Time to Buy? - Defense World
Axogen (FRA:LT3) Earnings Yield % : N/A% (As of Jan. 19, 2025) - GuruFocus.com
Axogen (FRA:LT3) 5-Year Yield-on-Cost % : 0.00 (As of Jan. 18, 2025) - GuruFocus.com
Assenagon Asset Management S.A. Sells 484,570 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen (NASDAQ:AXGN) Sets New 52-Week HighStill a Buy? - MarketBeat
AxoGen (AXGN) Moves 18.2% Higher: Will This Strength Last? - MSN
AxoGen, Inc. (NASDAQ:AXGN) Shares Bought by JPMorgan Chase & Co. - Defense World
Barclays PLC Raises Holdings in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Is Axogen (NASDAQ:AXGN) Using Too Much Debt? - Simply Wall St
Learn to Evaluate (AXGN) using the Charts - Stock Traders Daily
AxoGen, Inc. (AXGN) Soars to 52-Week High, Time to Cash Out? - Yahoo Finance
AxoGen (NASDAQ:AXGN) Hits New 12-Month High – Time to Buy? - Defense World
AxoGen (NASDAQ:AXGN) Reaches New 12-Month HighHere's What Happened - MarketBeat
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Axogen (STU:LT3) Enterprise Value : €694.5 Mil (As of Jan. 10, 2025) - GuruFocus.com
AxoGen (NASDAQ:AXGN) Trading Up 6.7%Here's What Happened - MarketBeat
Axogen stock soars to 52-week high, hits $17.24 - Investing.com India
Axogen sees Q4 revenue to be $49.4M - MSN
Axogen Reports Strong Revenue Growth and Market Expansion - TipRanks
Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2024 - The Manila Times
Axogen Reports Strong Q4: Revenue Surges 15% to $49.4M as Surgical Solutions Gain Traction - StockTitan
Axogen (STU:LT3) Cash Flow for Lease Financing : €0.0 Mil (TTM As of Sep. 2024) - GuruFocus.com
Axogen (STU:LT3) GF Value Rank : 3 (As of Jan. 09, 2025) - GuruFocus.com
Axogen (STU:LT3) Revenue per Share : €3.81 (TTM As of Sep. 2024) - GuruFocus.com
First Light Asset Management, LLC Increases Stake in Axogen Inc - GuruFocus.com
Principal Financial Group Inc. Makes New Investment in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen: Well Placed To Capitalize Growth At Higher Multiples (NASDAQ:AXGN) - Seeking Alpha
Axogen (FRA:LT3) Total Assets : €173.0 Mil (As of Sep. 2024) - GuruFocus.com
Axogen (FRA:LT3) Short-Term Capital Lease Obligation : €1.7 Mil (As of Sep. 2024) - GuruFocus.com
Axogen (FRA:LT3) PS Ratio : 4.17 (As of Jan. 05, 2025) - GuruFocus.com
AxoGen (NASDAQ:AXGN) Trading Down 4.8%What's Next? - MarketBeat
Jane Street Group LLC Cuts Stock Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
AxoGen, Inc. (NASDAQ:AXGN) Short Interest Down 7.3% in December - MarketBeat
Geode Capital Management LLC Buys 31,612 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Barclays PLC Purchases 39,182 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Barclays PLC Increases Stock Holdings in AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen, Inc. (NASDAQ:AXGN) Shares Acquired by Geode Capital Management LLC - MarketBeat
Axogen Inc (AXGN) Shares Down 3.3% on Dec 30 - GuruFocus.com
Franklin Resources Inc. Has $1.08 Million Position in AxoGen, Inc. (NASDAQ:AXGN) - Defense World
Axogen Inc (AXGN) Shares Down 4.15% on Dec 27 - GuruFocus.com
State Street Corp Purchases 95,051 Shares of AxoGen, Inc. (NASDAQ:AXGN) - Defense World
State Street Corp Acquires 95,051 Shares of AxoGen, Inc. (NASDAQ:AXGN) - MarketBeat
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run? - MSN
AxoGen (NASDAQ:AXGN) Shares Down 4.8%Here's What Happened - MarketBeat
Axogen, Inc. (NASDAQ:AXGN) Looks Just Right With A 29% Price Jump - Simply Wall St
AxoGen (NASDAQ:AXGN) Hits New 52-Week HighStill a Buy? - MarketBeat
(AXGN) Trading Advice - Stock Traders Daily
Axogen stock soars to 52-week high, reaches $15.95 - Investing.com
With 78% ownership in Axogen, Inc. (NASDAQ:AXGN), institutional investors have a lot riding on the business - Simply Wall St
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year? - MSN
Axogen Inc (AXGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):